Epilepsy Drugs Market with COVID-19 Impact Analysis, by Seizure Type (Generalized seizures, Focal seizures, Non-epileptic seizures), by Drugs Generation (Third Generation Drugs, Second Generation Drugs, First Generation Drugs), by Distribution Channel (Drug Stores and Retail Pharmacies, Hospital Pharmacies, Online Providers), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Epilepsy Drugs Market size was valued at USD 7,000 Million in 2022, expanding at a CAGR of 3.51% from 2023 to 2030.
Epilepsy medicines, often known as antiseizure or antiepileptic medications, are used to treat and control seizures in people suffering from epilepsy. These medications reduce the frequency and severity of seizures by controlling electrical activity in the brain. They are classified into several kinds, each of which targets a particular element of brain activity. It is critical to select the proper medicine and dosage to safely regulate seizure control while minimizing negative effects. Regular medical supervision is required to assess the drug\'s efficacy and change therapy as needed for persons with epilepsy to have a better quality of life.
Epilepsy Drugs Market- Market Dynamics
- The surge in new drug approvals in recent years and the rising global incidence of epilepsy cases
The Epilepsy drugs market is experiencing growth due to a surge in new drug approvals in recent years and the rising global incidence of epilepsy cases. This development reflects the growing need for effective treatments for controlling and managing seizures, which is encouraging pharmaceutical companies to expand to meet the requirements of people living with epilepsy. According to the World Health Organization\'s February 2022 update, approximately fifty million individuals globally have epilepsy, making it among the most frequent neurological illnesses worldwide. Each year, approximately 49 per 100,000 people in high-income nations receive a diagnosis of epilepsy. In low- and middle-income nations, this ratio can reach 139 per 100,000 people. The increasing prevalence of epilepsy creates a demand for treatment, which promotes market expansion.
Epilepsy Drugs Market- Key Insights
- As per the analysis shared by our research analyst, the global Epilepsy Drugs market is estimated to grow annually at a CAGR of around 3.51% over the forecast period (2023-2030)
- The Epilepsy Drugs industry is projected to grow at a significant rate due to the surge in new drug approvals in recent years and the rising global incidence of epilepsy cases.
- Based on seizure type segmentation, focal seizures was predicted to show maximum market share in the year 2022
- Based on drugs generation segmentation, second generation was the leading type in 2022
- Based on distribution channel segmentation, drug stores and retail pharmacies was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Epilepsy Drugs Market- Segmentation Analysis:
The Global Epilepsy Drugs Market is segmented on the basis of seizure type, drug generation, distribution channel, and Region.
The market is divided into three categories based on drug generation: third-generation drugs, second generation drugs, and first-generation drugs. The second-generation segment dominates the market due to numerous substantial improvements, including fewer drug-drug interactions, fewer potentially fatal side events, and a less unfavorable influence on cognitive processes. In addition, increased epilepsy cases would increase the demand for medications in the segment.
The market is divided into categories based on distribution channel: drug stores and retail pharmacies, hospital pharmacies, and online providers. Drug stores and retail pharmacies held the largest market share for epilepsy drugs in 2022 and are expected to maintain their dominance throughout the forecast period, due to the easy and quick access to a wide range of medication and adequate items in stock provided by these distribution channels, as well as the availability of these items at retail stores at discounted prices.
Epilepsy Drugs Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The North American region is predicted to develop significantly over the forecast period, owing to the rising prevalence of epilepsy and market participants\' strategic efforts, product releases, and awareness campaigns.
Epilepsy Drugs Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in March 2022, The United States Food and Drug Administration approved Lupin\'s abbreviated new drug application (ANDA) for Vigabatrin. It is an anti-epileptic medication that will be marketed as a USP oral solution (500 mg).
Recent Developments:
- In May 2023, Angelini Pharma, a division of privately held Angelini Industries, and JCR Pharmaceuticals Co., Ltd. disclosed a unique global commercialization and development contract for the creation of new biologic therapies to treat symptoms of epilepsy using J-Brain Cargo, blood-brain barrier penetrating technological devices.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL EPILEPSY DRUGS MARKET KEY PLAYERS
- UCB S.A.,
- Takeda Pharmaceutical Company Limited
- Sunovion Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Limited
- Sanofi SA
- Pfizer, Inc.
- Novartis AG
- Johnson & Johnson
- Lundbeck A/S
- GW Pharmaceuticals plc
- GlaxoSmithKline PLC
- Eisai Co., Ltd.
- Alkem Labs.
- Abbott Laboratories
GLOBAL EPILEPSY DRUGS MARKET, BY SEIZURE TYPE
- Generalized seizures
- Focal seizures
- Non-epileptic seizures
GLOBAL EPILEPSY DRUGS MARKET, BY DRUGS GENERATION
- Third Generation Drugs
- Second Generation Drugs
- First Generation Drugs
GLOBAL EPILEPSY DRUGS MARKET, BY DISTRIBUTION CHANNEL
- Drug Stores and Retail Pharmacies
- Hospital Pharmacies
- Online Providers
GLOBAL EPILEPSY DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Epilepsy Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Epilepsy Drugs Market Snippet by Seizure Type
2.1.2. Epilepsy Drugs Market Snippet by Drugs Generation
2.1.3. Epilepsy Drugs Market Snippet by Distribution Channel
2.1.4. Epilepsy Drugs Market Snippet by Country
2.1.5. Epilepsy Drugs Market Snippet by Region
2.2. Competitive Insights
3. Epilepsy Drugs Key Market Trends
3.1. Epilepsy Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Epilepsy Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Epilepsy Drugs Market Opportunities
3.4. Epilepsy Drugs Market Future Trends
4. Epilepsy Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Epilepsy Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Epilepsy Drugs Market Landscape
6.1. Epilepsy Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Epilepsy Drugs Market – By Seizure Type
7.1. Overview
7.1.1. Segment Share Analysis, By Seizure Type, 2022 & 2030 (%)
7.1.2. Generalized seizures
7.1.3. Focal seizures
7.1.4. Non-epileptic seizures
8. Epilepsy Drugs Market – By Drugs Generation
8.1. Overview
8.1.1. Segment Share Analysis, By Drugs Generation, 2022 & 2030 (%)
8.1.2. Third Generation Drugs
8.1.3. Second Generation Drugs
8.1.4. First Generation Drugs
9. Epilepsy Drugs Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
9.1.2. Drug Stores and Retail Pharmacies
9.1.3. Hospital Pharmacies
9.1.4. Online Providers
10. Epilepsy Drugs Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Epilepsy Drugs Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Epilepsy Drugs Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Epilepsy Drugs Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Epilepsy Drugs Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Epilepsy Drugs Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Seizure Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Drugs Generation, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Epilepsy Drugs Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. UCB S.A.,
11.2.2. Takeda Pharmaceutical Company Limited
11.2.3. Sunovion Pharmaceuticals Inc.
11.2.4. Sun Pharmaceutical Industries Limited
11.2.5. Sanofi SA
11.2.6. Pfizer, Inc.
11.2.7. Novartis AG
11.2.8. Johnson & Johnson
11.2.9. H. Lundbeck A/S
11.2.10. GW Pharmaceuticals plc
11.2.11. GlaxoSmithKline PLC
11.2.12. Eisai Co., Ltd.
11.2.13. Alkem Labs.
11.2.14. Abbott Laboratories
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
